Compounds > valine

valine and Huntington Disease

valine has been researched along with Huntington Disease in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (15.38)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (46.15)	29.6817
2010's	3 (23.08)	24.3611
2020's	2 (15.38)	2.80

Authors

Authors	Studies
Heim, B; Seppi, K	1
Rodrigues, FB; Wild, EJ	1
Bozigian, H; Grigoriadis, DE; Loewen, G; O'Brien, CF; Skor, H; Smith, EB	1
Jankovic, J; Niemann, N	1
Döbrössy, M; Dunnett, SB; Mazzocchi-Jones, D	1
Benaich, S; Durr, A; Mochel, F; Rabier, D	1
Alberch, J; Badenas, C; Canals, JM; Carrasco, JL; López, M; Milà, M; Muñoz, E	1
Abbruzzese, G; Bellone, E; Cattaneo, E; Ciotti, P; Di Maria, E; Mandich, P; Marasco, A; Novelli, G; Tartari, M	1
Gillis, T; Gusella, JF; Hakky, MM; Hayden, M; Kishikawa, S; Li, JL; MacDonald, ME; Myers, RH; Warby, S	1
Akkad, AD; Andrich, J; Arning, L; Epplen, JT; Kraus, PH; Mai, M; Saft, C; Wieczorek, S	1
Alberch, J; Canals, JM; del Toro, D; Egea, G; Ginés, S; Kojima, M	1
Beal, MF; Ferrante, RJ; Kowall, NW; Martin, JB; Swartz, KJ	1
Diamond, S; Hansen, S; Perry, TL; Stedman, D	1

Reviews

1 review(s) available for valine and Huntington Disease

Article	Year
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs, 2018, Volume: 78, Issue:5 Topics: Antipsychotic Agents; Drug Approval; Humans; Huntington Disease; Tardive Dyskinesia; Tetrabenazine; Tourette Syndrome; United States; United States Food and Drug Administration; Valine; Vesicular Monoamine Transport Proteins	2018

Other Studies

12 other study(ies) available for valine and Huntington Disease

Article	Year
Valbenazine as treatment for Huntington's disease chorea. The Lancet. Neurology, 2023, Volume: 22, Issue:6 Topics: Chorea; Humans; Huntington Disease; Tetrabenazine; Valine	2023
Huntington's Disease Clinical Trials Corner: April 2020. Journal of Huntington's disease, 2020, Volume: 9, Issue:2 Topics: Clinical Trials as Topic; Genetic Therapy; Humans; Huntington Disease; Randomized Controlled Trials as Topic; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins	2020
Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine. Drugs in R&D, 2017, Volume: 17, Issue:3 Topics: Adrenergic Uptake Inhibitors; Adult; Chromatography, Liquid; Female; Humans; Huntington Disease; Isomerism; Male; Middle Aged; Tandem Mass Spectrometry; Tardive Dyskinesia; Tetrabenazine; Valine	2017
Embryonic striatal grafts restore bi-directional synaptic plasticity in a rodent model of Huntington's disease. The European journal of neuroscience, 2009, Dec-03, Volume: 30, Issue:11 Topics: Animals; Biophysics; Chi-Square Distribution; Corpus Striatum; Disease Models, Animal; Electric Stimulation; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Huntington Disease; In Vitro Techniques; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Recovery of Function; Synapses; Tissue Transplantation; Valine	2009
Validation of plasma branched chain amino acids as biomarkers in Huntington disease. Archives of neurology, 2011, Volume: 68, Issue:2 Topics: Adult; Aged; Amino Acids, Branched-Chain; Biomarkers; Early Diagnosis; Female; Genotype; Heterozygote; Humans; Huntingtin Protein; Huntington Disease; Isoleucine; Leucine; Linear Models; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Predictive Value of Tests; Severity of Illness Index; Trinucleotide Repeat Expansion; Valine	2011
Association between BDNF Val66Met polymorphism and age at onset in Huntington disease. Neurology, 2005, Sep-27, Volume: 65, Issue:6 Topics: Adult; Age of Onset; Amino Acid Substitution; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Huntingtin Protein; Huntington Disease; Male; Methionine; Middle Aged; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Polymorphism, Genetic; Trinucleotide Repeat Expansion; Valine	2005
No evidence of association between BDNF gene variants and age-at-onset of Huntington's disease. Neurobiology of disease, 2006, Volume: 24, Issue:2 Topics: Adolescent; Adult; Age of Onset; Amino Acid Substitution; Brain; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Genetic Testing; Genetic Variation; Genotype; Humans; Huntington Disease; Male; Methionine; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Silencer Elements, Transcriptional; Trinucleotide Repeat Expansion; Valine	2006
Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease. Neurobiology of disease, 2006, Volume: 24, Issue:2 Topics: Age of Onset; Alzheimer Disease; Amino Acid Substitution; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Haplotypes; Huntington Disease; Introns; Methionine; Polymorphism, Single Nucleotide; Trinucleotide Repeat Expansion; Valine	2006
No association between polymorphisms in the BDNF gene and age at onset in Huntington disease. BMC medical genetics, 2006, Nov-10, Volume: 7 Topics: Adult; Age Factors; Age of Onset; Brain-Derived Neurotrophic Factor; Codon; Humans; Huntington Disease; Methionine; Middle Aged; Polymorphism, Single Nucleotide; Trinucleotide Repeats; Valine	2006
Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, Dec-06, Volume: 26, Issue:49 Topics: Amino Acid Substitution; Animals; Brain-Derived Neurotrophic Factor; Cell Line; Cell Line, Transformed; Golgi Apparatus; Humans; Huntingtin Protein; Huntington Disease; Methionine; Mice; Mice, Mutant Strains; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Polymorphism, Single Nucleotide; Protein Transport; Signal Transduction; Valine	2006
Systemic approaches to modifying quinolinic acid striatal lesions in rats. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1988, Volume: 8, Issue:10 Topics: 2-Amino-5-phosphonovalerate; Allopurinol; Amino Acids; Animals; Antioxidants; Baclofen; Corpus Striatum; Dibenzocycloheptenes; Disease Models, Animal; Dizocilpine Maleate; Huntington Disease; Ketamine; Male; Neuropeptide Y; Nimodipine; Peptides; Pyridines; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; Substance P; Taurine; Valine	1988
Plasma-aminoacid levels in Huntington's chorea. Lancet (London, England), 1969, Apr-19, Volume: 1, Issue:7599 Topics: Adult; Alanine; Amino Acids; Female; Humans; Huntington Disease; Isoleucine; Leucine; Male; Middle Aged; Proline; Schizophrenia; Tyrosine; Valine	1969